Menu

News & events

Keep up-to-date with the latest Synthetic Biology information from across the industry


4-day MBA “More Business Acumen”

19 November 2017

View event
Stephen Chambers

@spchambers007

  • 1
  • 1
SynbiCITE

@SynbiCITE

  • 0
  • 0
Professor Paul Freemont speaks on BBC Inside Science

The speed and ease of precise infection diagnosis could be transformed by synthetic biologists at Imperial College, London. Paul Freemont tells Adam a...

Read blog article
Jennifer Doudna talks to Jim al-Khalili on CRISPR/cas9

Jennifer Doudna, developer of the gene editing system called CRISPR/cas9, talks to Jim al-Khalili.

Read blog article
Prominent players in the UK’s thriving synbio sector

SynbiCITE looks at some of the companies leading the way in UK synthetic biology, creating innovative new technologies and driving the growth of the UK bioeconomy.

Read blog article
Stephen Chambers

@spchambers007

  • 0
  • 0
Stephen Chambers

@spchambers007

  • 4
  • 2
Looking ahead: Conference season has arrived

As the summer draws to a close, the life science sector once again gears up for conference season. Here we take a look at some events we are particularly excited about:

Read blog article
World leading DNA technology is expanding its operations in London as it grows to meet global DNA demand

Touchlight Genetics Ltd has developed a revolutionary DNA technology that can synthetically manufacture commercial scale DNA in a two-week process – a...

Read article
Bio-start 2.0

On 11th of July 2017, 11 months to the day from the launch of the Bio-start competition, CustoMem was announced as the overall winner, receiving £100k. Bio-start was met with widespread enthusiasm and support, and SynbiCITE fully intend to take the competition into its second year in 2018, with new sponsors, mentors and an eager new cohort of start-ups.

Read blog article
London DNA Foundry

@DNAFoundry

  • 1
  • 2
London DNA Foundry

@DNAFoundry

  • 5
  • 3
London DNA Foundry

@DNAFoundry

  • 2
  • 1
Bio-Start UK

@BioStartUK

  • 5
  • 3
Synthetic biology – does industry get it?

As part of the conference series ‘Breakthrough science and technologies: transforming our future’, the Royal Society hosted a conference posing the question ‘Synthetic biology – does industry get it?’. Read the conference report here.

Read blog article
London DNA Foundry

@DNAFoundry

  • 0
  • 1
Touchlight welcomes Dr. Geoff Smith

Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.

Read article
Bio-Start UK

@BioStartUK

  • 1
  • 1
Innovations in cell-free synthetic biology are transforming biotechnology

Richard Kelwick and Professor Paul Freemont comment on The Economist's article on cell-free synthetic biology “Cell-free biotech will make for better products”.

Read blog article
SynBioBeta London 2017

2017 saw another successful year for SynBioBeta London, with synthetic biology researchers, investors and enthusiasts alike flocking to London for lively talks and great networking. Read SynbiCITE's insights on the event here.

Read blog article
Synthetic Biology UK 2017

27 November 2017

View event
A look forward to SynBioBeta London 2017

The annual SynBioBeta London Conference, now in its 5th year, will return to London from the 4th-6th April 2017. With this exciting event less than a ...

Read blog article
Bio-Start UK

@BioStartUK

  • 11
  • 7
Bio-start: the story so far and looking forward to the final

​As 2017 kicks off, we take a look back at the last 4 months of the Bio-start competition, and at what is to come as it progresses this year.

Read blog article
Bio-Start UK

@BioStartUK

  • 0
  • 1
Lean LaunchPad for Synthetic Biology Review

As this Autumn’s Lean Launchpad for Synthetic Biology drew to a close, the teams described the lessons learned from the programme. William Pelton who ...

Read blog article
International Genetically Engineered Competition (iGEM) 2016

Attributed to Eleanor Chambers iGEM volunteer The 2016 Giant Jamboree took place at the Hynes Convention Center in downtown Boston last week (Oct 27-...

Read blog article
Bio-start Confirms Sir Richard Sykes as Chair of Judging Panel

SynbiCITE and Rainbow Seed Fund today announce that Sir Richard Sykes, Chairman of the Royal Institution of Great Britain, Chairman of Imperial Colleg...

Read article
Synthetic Biology Publications: Top Ten

Synthetic biology first entered the scientific lexicon in 1970s in the wake of the then recent developments in recombinant DNA technology when Waclaw ...

Read blog article
SynbiCITE to Sponsor ‘Best Emerging UK Synthetic Biotech Company’ Award at OBN Awards 2016

​SynbiCITE is proud to be sponsoring the ‘Best Emerging UK Synthetic Biotech Company’ Award at the 2016 OBN awards on the 6rd of October.

Read article
SynbiCITE and Rainbow Seed Fund Announce New £200k Competition for Engineering Biology

SynbiCITE and Rainbow Seed Fund announce the launch of Bio-Start, an annual competition to support early stage companies in the field of synthetic biology.

Read article
Lean LaunchPad for Synthetic Biology Alumni: Where are they now? Part 2

Gabriella Santosa and Florence Gschwend were awarded the prestigious 2016 Althea PrizeIn the latest of our occasional series, we look at past particip...

Read blog article
The Second Human Genome Project: HGP-Write

Professor Paul Freemont discuses the potential sequel to the Human Genome Project: HGP-Write.

Read blog article
IET/SynbiCITE Joint Workshop and Conference on Engineering Biology

SynbiCITE and the IET are planning a joint Engineering Biology workshop and conference for December 2016.

Read blog article
SynbiCITE Partner CustoMem wins 2016 Althea-Imperial Prize

Customem wins £10,000 for innovative use of synthetic biology to create membranes that filter pollutants from wastewater.

Read article
'Living Factories of the Future' Featured in Nature

A recent feature in Nature focuses on the various ways industry and academia hope to automate and industrialise Synthetic Biology, including SynbiCITE's upcoming DNA Foundry.

Read article
Stephen Chambers

@spchambers007

  • 1
  • 0
SynbiCITE

@SynbiCITE

  • 0
  • 0
SynbiCITE

@SynbiCITE

  • 2
  • 0
SynbiCITE

@SynbiCITE

  • 0
  • 0
SynbiCITE

@SynbiCITE

  • 1
  • 0
Stephen Chambers

@spchambers007

  • 0
  • 0
SynbiCITE

@SynbiCITE

  • 2
  • 0
SynbiCITE

@SynbiCITE

  • 5
  • 6
SynbiCITE

@SynbiCITE

  • 2
  • 6
Stephen Chambers

@spchambers007

  • 3
  • 6
A vibrant synthetic biology ecosystem has developed in the UK – promising new jobs and valuable technology

A survey of synthetic biology company start-ups in the UK is published today by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem sustaining a thriving and rapidly growing sector of the bioeconomy.

Read article
Bio-Start UK

@BioStartUK

  • 10
  • 8
Bio-Start UK

@BioStartUK

  • 1
  • 3
Bio-Start UK

@BioStartUK

  • 2
  • 1
Q&A with Tara Hill, Twist Bioscience

A Q&A with Tara Hill of Twist Bioscience about how she started out in science and business

Read blog article
Steve Bates brings synthetic biology to Buckingham Palace

Innovation meets tradition as Steve Bates, CEO of BIA, becomes the first person to wear spider silk while being honoured at Buckingham Palace.

Read blog article
London DNA Foundry

@DNAFoundry

  • 1
  • 4
Synpromics raises £5.2m of new investment

Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M. Participants included existing investors Calculus Capital, the Scottish Investment Bank, the investment arm of Scottish Enterprise and private shareholders.

Read article
Two new start-up plans win BrisSynBio’s first synthetic biology entrepreneurship competition

Two start-ups' proposals have been chosen as the winners of the first competition to discover and accelerate new synthetic biology companies at the University of Bristol.

Read article
Scientists engineer baker's yeast to produce penicillin molecules

The synthetic biologists from Imperial College London have re-engineered yeast cells to manufacture the nonribosomal peptide antibiotic penicillin. In laboratory experiments, they were able to demonstrate that this yeast had antibacterial properties against streptococcus bacteria.

Read article
London DNA Foundry

@DNAFoundry

  • 3
  • 3
Engineering Biology for a Better World

Two recent events saw SynbiCITE working in partnership with OBN to connect with new audiences; a Senior Executive Breakfast at the Royal Academy of Engineering in London in late February, and the BioTuesday on ‘Engineering Biology for a Better World’ at the Mathematical Institute in Oxford in early March. Both drew on the idea of engineering biology as a technology with the power to ‘heal us, feed us and fuel us’.

Read blog article
Investing in a better future: a look forward to the SynbiCITE Investor Breakfast at the House of Lords

Engineering biology is a catalyst for growing the global bioeconomy, and represents a clear money making opportunity. It will shape our future and is ...

Read blog article
Bio-start Selects First Cohort: 15 companies join Bio-start’s inaugural synthetic biology accelerator

Bio-start is pleased to announce the 15 companies that will be joining the UK’s first synthetic biology accelerator programme. Applicants from across ...

Read article
DIY Labware: the advanced cupholder

Sometimes your liquid handling robot needs to be able to use tubes but they have to be placed in exactly the correct position every time. 3D printing ...

Read blog article
Bio-Start UK

@BioStartUK

  • 1
  • 1
LGC and Desktop Genetics receive SynbiCITE funding to develop novel methods for CRISPR genome editing analysis

Desktop Genetics and LGC have been awarded funding from SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology, to develop screening and validation tools for functional genomics, cell line engineering and synthetic biology.

Read article
Professors Jay Keasling and Chris Voigt Announced as Keynote Speakers at the SynbiCITE & IET Engineering Biology Conference

The 1st International Conference on Engineering Biology, co-founded by SynbiCITE and the Institution of Engineering and Technology (IET), has announced world experts Professor Jay Keasling and Professor Chris Voigt as keynote speakers.

Read article
Synthetic Biology and Biomedicine

Engineering microenvironmental sensitive devices for targeted therapies With rapidly progressing rational design of synthetic devices, synthetic biol...

Read blog article
SynbiCITE Join BIA Promoting UK Companies at SynBioBeta, San Francisco 2016

SynbiCITE, along with the BIA – the UK’s biotechnology trade association - is headed to San Francisco, USA, to promote the UK synthetic biology industry to their American counterparts, as well as industry leaders and investors.

Read article
SynbiCITE and Business Reporter release 'Nature Knows Best' Synthetic Biology Documentary

SynbiCITE has produced the synthetic biology documentary ‘Nature Knows Best’ in partnership with Business Reporter magazine.

Read article
OBN announce the finalists for Best Emerging UK Synthetic Biology Company

Oxitec winner of the 2015 Best Emerging UK SynBio Company OBN announced the finalists of its 8th Annual Awards covering Biotech, Medtech, Synthetic B...

Read article
SynbiCITE Fact-Finding Mission to China

SynbiCITE reports on its recent fact-finding mission to China and the state of Sino-synbio.

Read blog article
The UK’s First Bio-Hackathon to take place in Cambridge

​The UK’s first Bio-Hackathon takes place in Cambridge this week from 21st – 25th June.

Read article
UK's First Commercial Synthetic Biology Foundry Goes Into Production

SynbiCITE has officially launched its synthetic biology Foundry, providing automated end-to-end design, construction and validation of synthetic biologic components.

Read article
Professor Paul Freemont delivers Ellison-Cliffe Lecture

​You can now watch Synbicite co-director Professor Paul Freemont deliver the Royal Society of Medicine’s annual Ellison-Cliffe Lecture.

Read article
SynbiCITE

@SynbiCITE

  • 14
  • 6
SynbiCITE

@SynbiCITE

  • 0
  • 0
SynbiCITE

@SynbiCITE

  • 0
  • 0
Stephen Chambers

@spchambers007

  • 1
  • 2
Stephen Chambers

@spchambers007

  • 4
  • 4
SynbiCITE

@SynbiCITE

  • 1
  • 2
Stephen Chambers

@spchambers007

  • 1
  • 2
Synpromics expands facilities to meet demand for revolutionary gene control technology

Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the Roslin Innovation Centre.

Read article
Stephen Chambers

@spchambers007

  • 3
  • 1
Stephen Chambers

@spchambers007

  • 0
  • 4
Bio-start Awards 2017

Bio-start awards over £100K in zero-equity prizes to 6 high-impact start-ups Bio-start celebrates UK innovative start-ups with commercial ideas that ...

Read blog article
UK Synthetic Biology Start up Survey 2017

We would like to invite you to the Breakfast Seminar Launch of SynbiCITE’s UK Synthetic Biology Start-up Survey on Friday 21st July 2017, at 9.00-10:4...

Read article
Bio-start Awards 2017: Finalists Announced

​On Tuesday 11th July 2017, the finals and awards for the first annual Bio-start competition will take place. Read about the finalists here.

Read blog article
Q&A with Bio-Start mentor James Hallinan

A Q&A with James Hallinan about his experience as a mentor with the Bio-Start engineering biology competition

Read blog article
Bio-start Awards 2017

Tickets for the Bio-start Awards 2017 are on offer now, and spaces are limited. To register your place for free, visit the Bio-start Awards 2017 sign up on Eventbrite.

Read blog article
Engineering Biology: the new IET open access journal

​The Institution of Engineering and Technology (IET) has launched a new journal, entitled Engineering Biology, to reflect the fact that synthetic biology/engineering biology is, fundamentally, now widely recognised as a field of engineering.

Read blog article
Japanese government delegation seeks SynbiCITE’s advice on start-ups creation and synthetic biology business opportunities

A recent UK visit by a high-level Japanese delegation of government officials and industrialists recognises the tremendous progress the UK has made, building on its established lead in Europe, towards becoming a major global biotech cluster.

Read blog article
London DNA Foundry

@DNAFoundry

  • 7
  • 11
London DNA Foundry

@DNAFoundry

  • 0
  • 1
London DNA Foundry

@DNAFoundry

  • 4
  • 4
East African Collaborations in Practical Synthetic Biology Workshop

From the 15th-17th March 2017 SynbiCITE will attend a workshop to establish UK-East African collaborations in practical synthetic biology, taking plac...

Read article
London DNA Foundry

@DNAFoundry

  • 14
  • 16
The London DNA Foundry Launches New Website

Based at Imperial College, the London DNA Foundry is a core facility at SynbiCITE, and has recently launched a new website.

Read article
Prokarium and Probiomed in UK-Mexico Collaboration to Scale-Up Manufacture of Thermostable Vaccines with a Focus on Diarrhoea

Keele, UK and Mexico City, MX, 4th January 2017 / Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture...

Read article
Bio-Start UK

@BioStartUK

  • 1
  • 2
SynbiCITE response to Government announcement on extra investment for science

SynbiCITE welcomes yesterday’s announcement by the Government of an additional £2billion investment per year for UK science R&D by the end of this parliament. SynbiCITE Co-Director’s Professors Richard Kitney and Paul Fremont share their thoughts.

Read article
First look at the latest applications for Bio-start

Applications from a range of sectors across the UK continue to arrive for Bio-start, the competition to incentivise innovative early-stage companies a...

Read article
Future Innovations in Synthetic Biology Forum

The Institute of Child Health in London will host a Synthetic Biology Innovation Forum on 11th October 2016. This event will bring together leading Sy...

Read article
‘Building a Biotech Business from Scratch’: IBioIC announces a 4-day MBA ‘More Business Acumen’ from 20-24 November in Glasgow

​The Industrial Biotechnology Innovation Centre (IBioIC), in association with SynbiCITE, will hold a 4-Day MBA in Glasgow from 20-24 November, aiming to develop the entrepreneurship of future biotechnology leaders.

Read article
Some Thoughts on the Engineering of Biology

Prof Richard Kitney, Co-Director SynbiCITEIt is almost a decade and a half since Tom Knight introduced the concept of BioBricks, or standard biologica...

Read blog article
Cambridge Consultants spin-out Evonetix poised to transform synthetic biology industry

Cambridge Consultants announced the launch of a new DNA synthesis spin-out company, Evonetix. The joint venture, supported by technology entrepreneur ...

Read article
Applications Open for Lean Launchpad for Synthetic Biology 2016

SynbiCITE is now accepting applications for the next Lean Launchpad for Synthetic Biology, which will be run from September to November 2016.

Read article
Lean LaunchPad for Synthetic Biology Alumni: Where are they now? Part 1

The entrepreneurial programme Lean Launchpad for Synthetic Biology returns to London this autumn. Where are last year's budding entrepreneurs now?

Read blog article
Professor Paul Freemont on Radio 4

Professor Paul Freemont on BBC Radio 4 Today programme discussing latest development in synthetic biology following publication of Craig Venter's 'minimal genome' paper in Science

Read article
Breathing chandeliers and algae sculptures: bionic art comes to the V&A

Arborea, based in Imperial College’s White City innovation hub, has been featured in the Financial Times.

Read article
NPL and Imperial College London Launch a New Virtual Lab to Establish the UK Centre for Engineering Biology, Metrology and Standards

NPL, the UK's National Measurement Institute (NMI), and SynbiCITE at Imperial College London, have announced the establishment of a new £7 million virtual lab to underpin their joint Centre for Engineering Biology, Metrology and Standards to help the UK synthetic biology industry improve the manufacturing and adoption of new products - in partnership with LGC and NIBSC.

Read article
£17 million boost to the UK’s leading life sciences sector

The Chancellor of the Exchequer, Philip Hammond, announced this week £17million new funding will be supplied for UK life science, helping to create real benefits for the NHS and patients.

Read article
SynbiCITE

@SynbiCITE

  • 7
  • 11
Stephen Chambers

@spchambers007

  • 1
  • 2
Synpromics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2017

SynbiCITE congratulates Synpromics as the winner of Best Emerging UK Synthetic Biotech Company at OBN’s 9th Annual Awards.

Read article
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development Speaking...

Read article
Three upcoming Innovation Funding competitions through InnovateUK

​InnovateUK, the UK’s innovation agency, has three forthcoming Innovation Funding Competitions that opened recently.

Read article
Stephen Chambers

@spchambers007

  • 1
  • 5
SynbiCITE

@SynbiCITE

  • 5
  • 3
London DNA Foundry

@DNAFoundry

  • 2
  • 0
London DNA Foundry

@DNAFoundry

  • 0
  • 1
CustoMem wins £100K 1st Prize in Bio-start competition

SynbiCITE and Rainbow Seed Fund congratulate CustoMem as winners of the 1st Prize in the Bio-start competition for companies using engineering biology to solve significant global problems.

Read article
Q&A with Bio-Start mentor Debra Conway

Q&A with Bio-Start mentor Debra Conway Managing Director, CyBio Northern Europe.Bio-Start: What in your background makes you a good mentor to the ...

Read blog article
London DNA Foundry

@DNAFoundry

  • 1
  • 7
Update: Investing for the long haul

The Rainbow Seed Fund – one of the founders of the Bio-start award – is seeking early-stage companies for high growth, high-risk investment. The RSF combines the best of the public and private sectors to capitalise companies spun out from the UK’s research base in synthetic biology.

Read blog article
Shooting for the moon: SynbiCITE share industrial knowledge at GP-write

On May 9th and 10th, 2017 around 250 scientists, industry leaders, policy makers and ethicists gathered at the New York Genome Center for the second meeting of GP-write. GP-write is an open, international collaboration that aims to reduce by 1,000-fold within 10 years the costs of engineering and testing large genomes in cell lines. Dr David McClymont, Head of Automation, The London DNA Foundry, shares his thoughts. 

Read blog article
Who owns CRISPR?

Who owns CRISPR: this blog looks at the long and contentious battle over the intellectual property rights to this breakthrough technology.

Read blog article
London DNA Foundry

@DNAFoundry

  • 7
  • 7
Lab automation or robotic scientists: Dr McClymont and Professor Freemont share their views in Nature Biotechnology

Dr David McClymont, head of automation at the London DNA Foundry, and Professor Paul Freemont, Co-director of the London DNA Foundry and the EPSRC Cen...

Read article
London DNA Foundry

@DNAFoundry

  • 6
  • 3
SynbiCITE is a proud sponsor of the ‘Best Emerging UK Synthetic Biology Company’ at the OBN Awards 2017

SynbiCITE is pleased to announce once again they will be sponsoring the ‘Best Emerging UK Synthetic Biology Company’ at the 9th Annual OBN Awards, 2017. This award recognises the emerging industrial or synthetic biology company that has the most promise.

Read article
London DNA Foundry

@DNAFoundry

  • 6
  • 14
Reviewing the IET-SynbiCITE Engineering Biology Conference 2016

December 2016 saw the 1st International Conference on Engineering Biology take place in London. Here we look back over some conference highlights and award winners.

Read blog article
Synpromics announces a research collaboration with GE Healthcare to Extend the Toolbox for Production of Biologics

Edinburgh, UK, 4th January 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collabora...

Read article
Bio-start Competition Announces Additional Cash Prizes and Sponsors

SynbiCITE and Rainbow Seed Fund today announce new sponsors and prizes for the Bio-start competition, designed to commercialise the engineering of biology. The addition of new sponsors increases the number of prizes available to competitors including the free use of laboratory space around the UK.

Read article
Synbio Start-up Accelerator and Mentoring Programme

Running from February – April 2017, the Bio-start accelerator will provide direct access to connections that matter most in the industry. All entrants accepted into the programme will receive substantial mentoring and exposure to our global business and investor network.

Read article
Touchlight Genetics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2016

SynbiCITE congratulates Touchlight Genetics as the winner of Best Emerging UK Synthetic Biotech Company at the OBN’s 8th Annual Awards Ceremony held l...

Read article
Bio-start Announces David Lawrence as Competition Finalist Judge

SynbiCITE and Rainbow Seed Fund today announce that Dr David Lawrence, Non-executive Director at Syngenta and Chairman of the Science and Technology A...

Read article
Prokarium to Develop First Vaccine to Protect Against Sexually Transmitted and Insect-Borne Zika Infections

Keele, UK, 13th September 2016 / Prokarium today announced the start of its programme to develop an oral vaccine against Zika virus infection. Using t...

Read article
Entrepreneur Q&A: Ted Fjallman

Q: What is your background?A: Scientist – I liked physics and genetics, but I was already interested in business and communication (and history) at a ...

Read blog article
Prokarium receives £2M in Government contracts to develop new vaccines against emerging diseases and bioterrorist threats

Keele, UK, 25th July 2016 – Prokarium today announced the award of funding from the UK and Mexican Governments for the development of three new vaccin...

Read article
CRISPR-Cas9 genome editing partners with CAR-T cell therapy

The CRISPR-Cas9 system has rapidly become an indispensable tool in research labs around the world. Now it is finding an application as a therapeutic.

Read blog article
MassChallenge UK

Special offer to all SynbiCITE Partners Are you an early stage venture ready to accelerate your business? Want to be part of a global network of mento...

Read article
Lean LaunchPad for Synthetic Biology: Autumn 2016

The entrepreneurial programme Lean LaunchPad for Synthetic Biology returns to London this autumn.

Read blog article
SynbiCITE Collaborator Bento Bioworks Completes Beta Testing

​SynbiCITE collaborator and Lean Launchpad graduate Bento Bioworks has completed beta testing of Bento lab, their portable and affordable DNA lab, and have raised funding for their first production run.

Read article